You just read:

Synthetic Biologics Confirms Key Features of Pivotal Phase 2b/3 Trial of SYN-010 Pursuant to Consultations with FDA

News provided by

Synthetic Biologics, Inc.

18 Jan, 2017, 16:09 ET